This report is from this week’s CNBC’s UK Exchange newsletter. Each Wednesday, Ian King brings you expert insights on the most important business stories from the U.K. and other key developments you won’t want to miss. Like what you see? You can subscribe here.
Asked to name an industry in which the U.K. excels, many in business would cite life sciences.
In AstraZeneca
and GSK
, the country boasts two of the world’s 15 largest pharmaceutical companies — only the United States and Switzerland can match that — and, in Cambridge, Oxford and Imperial College London, three of the world’s top 10 universities for life sciences. It is also one of the top five global investment destinations for life sciences research.
